TLDR Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.
This web-based study from India examined the frequency and characteristics of mucocutaneous reactions to COVID-19 vaccines. The majority (73.6%) of the respondents had received the Covishield vaccine (AstraZeneca-Oxford), while 26.4% had been vaccinated with Covaxin (Bharat Biotech-ICMR). Post-vaccination mucocutaneous effects were experienced by 87 (19.6%) participants. The most common mucocutaneous finding was a local injection site reaction, followed by urticarial rash, exacerbation of preexisting dermatoses, and other conditions. Anaphylaxis was reported in three individuals, but no fatalities were reported. The study concluded that the majority of reactions were mild and self-limiting, and these outcomes should not discourage people from getting vaccinated.
33 citations,
June 2021 in “Dermatologic Therapy” COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.
1 citations,
January 2010 in “Elsevier eBooks” Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.
105 citations,
September 1995 in “Journal of The American Academy of Dermatology” Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.
1 citations,
October 2022 in “Current Dermatology Reports” COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.
research Skin
2 citations,
January 2011 in “Elsevier eBooks” Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.
60 citations,
September 2013 in “Alimentary Pharmacology & Therapeutics” Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.